Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2020-05-05 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Please find enclosed Certificate from a Practicing Company Secretary in compliance with Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2020-05-05 English
We are enclosing herewith Compliance Certificate, duly signed by the Compliance Officer of the Company and the Registrar and Share Transfer Agent, KFin Technologies Private Limited (SEBI ....
Regulatory Filings
2020-04-29 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated April 21, 2020, from Cipla Limited announcing the establishment of a COVID-19 dedicated fund and various relief efforts related to the pandemic. It is addressed to stock exchanges and includes no financial statements, detailed financial performance data, or regulatory filings. The content focuses on corporate social responsibility and public communication rather than financial results or governance changes. It is not an annual or interim report, earnings release, management discussion, or any regulatory filing. The document is a public relations announcement about the company's COVID-19 response initiatives, which fits the category of a press release or general regulatory announcement. Given the absence of any other specific filing type, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2020-04-21 English
Press Release - Cipla stands strong with India in the battle against COVID-19.
Regulatory Filings
2020-04-21 English
Allotment of ESOP/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification dated April 13, 2020, addressed to stock exchanges and regulatory bodies regarding the allotment of 3,910 equity shares under the company's Employee Stock Option Scheme (ESOP). It mentions the increase in issued share capital due to this allotment. The content is an announcement of a capital change event, specifically the allotment of shares, which affects the company's capital structure. The document is short (2295 characters) and does not contain financial statements or detailed financial analysis. It is not a full report but an update on a capital event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2020-04-13 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 13th ....
Regulatory Filings
2020-04-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.